Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-5
Abstract
The clinical outcome of autologous adipose stem cell (ASC) treatment of patients with multiple sclerosis (MS) was investigated following one year of observation.Methods. The clinical and MRI outcomes of 16 ASC-treated patients with RRMS and SPMS are reported after a one-year follow-up period.Results.At 18 months of follow-up, some patients showed “enticing” improvements on some exploratory efficacy measures, although a significant benefit was not observed for any measure across the entire group. Neither the progression of disability nor relapses were observed in any cases. In four patients, we found new gadolinium+ (Gd+) lesions on MRI. Our results indicate that ASC therapy is safe and does not produce any substantial side effects. Disease progression-free survival (PFS) of 18 months was seen in all patients with RRMS and SPMS. In these patients, EDSS scores did not progress above baseline scores. Gd-enhancing lesions were observed in two cases with RRMS, but these patients did not exhibit changes in EDSS score.Conclusion. Intrathecal treatment with ASCs is an attractive form of therapy for patients with MS but should be reserved for cases with aggressive disease progression, for cases that are still in the inflammatory phase, and for the malignant form.Keywords
Funding Information
- Central Clinical Hospital of the Ministry of National Defense in Warsaw (328)
This publication has 16 references indexed in Scilit:
- Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune EncephalomyelitisCell Transplantation, 2015
- Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsWorld Journal of Stem Cells, 2015
- Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALSStem Cells, 2014
- Incidence and prevalence of multiple sclerosis in Europe: a systematic reviewBMC Neurology, 2013
- Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune EncephalomyelitisStem Cells, 2009
- Multiple sclerosis and the major histocompatibility complexCurrent Opinion in Neurology, 2009
- Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcomeMultiple Sclerosis Journal, 2007
- Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two casesMultiple Sclerosis Journal, 2007
- The epidemiology of multiple sclerosis in EuropeEuropean Journal of Neurology, 2006
- Multiple sclerosisBest Practice & Research Clinical Haematology, 2004